Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|May 28, 2009
Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid IIChristopher S Lunde, Stephanie R Hartouni, James W Janc, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2006
Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureusNoe Reyes, Robert Skinner, Bret M Benton, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2007
Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibioticsMark H Gotfried, Jeng-Pyng Shaw, Bret M Benton, et al.
Journal of Bacteriology|December 4, 2004
Large-scale identification of genes required for full virulence of Staphylococcus aureusBret M Benton, J P Zhang, Skip Bond, et al.
Diagnostic Microbiology and Infectious Disease|October 23, 2012
In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumoniaKevin M Krause, Johanne Blais, Stacey R Lewis, et al.
Antimicrobial Agents and Chemotherapy|April 21, 2010
Specificity of induction of the vanA and vanB operons in vancomycin-resistant enterococci by telavancinCraig M Hill, Kevin M Krause, Stacey R Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2015
Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical spaceAudrey G Ross, Bret M Benton, Donovan Chin, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureusDeborah L Higgins, Ray Chang, Dmitri V Debabov, et al.
ACS Infectious Diseases|December 16, 2017
Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted MetabolomicsChristopher M Rath, Bret M Benton, Javier de Vicente, et al.
Journal of Medicinal Chemistry|September 19, 2018
Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and IsoxazolinePatrick S Lee, Guillaume Lapointe, Ann Marie Madera, et al.
Pageof 3